Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone.
Lindley C, Goodin S, McCune J, Kane M, Amamoo MA, Shord S, Pham T, Yowell S, Laliberte K, Schell M, Bernard S, Socinski MA. Lindley C, et al. Among authors: shord s. Am J Clin Oncol. 2005 Jun;28(3):270-6. doi: 10.1097/01.coc.0000145983.35929.2a. Am J Clin Oncol. 2005. PMID: 15923800 Clinical Trial.
A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer.
Gillenwater HH, McCune JS, Lindley C, Faucette S, Shord S, Donahue A, Socinski MA, Stewart CF, Zamboni WC, Kirstein MN, Moore D. Gillenwater HH, et al. Among authors: shord s. Cancer Invest. 2005;23(6):511-9. doi: 10.1080/07357900500201400. Cancer Invest. 2005. PMID: 16203659 Clinical Trial.
Coagulation products and their uses.
Shord SS, Lindley CM. Shord SS, et al. Am J Health Syst Pharm. 2000 Aug 1;57(15):1403-17; quiz 1418-20. Am J Health Syst Pharm. 2000. PMID: 10938981 Review.
62 results